Vildagliptin and Metformin Hydrochloride Tablets in India

Diabetes is not just a lifestyle disease; it has become one of the most common health issues all over the world. Over 100 million people are living with Type 2 Diabetes. However, the demand for effective, well-tolerated, and affordable treatment options has never been high. There are various therapeutic options available today, but the combination of Viladgliptin and Metformin Hydrochloride has emerged as a clinically preferred choice to manage your blood sugar in Type 2 diabetic patients.

This blog covers everything you need to know about the Vildagliptin and Metformin Hydrochloride tablets available in India. We will also discuss how they work, which brands are available, and their strengths.

What Are Vildagliptin and Metformin Hydrochloride Tablets?

Vildagliptin and Metformin Hydrochloride Tablets are the fixed-dose combination (FDC) of two important anti-diabetic drugs. Each drug plays a different role in blood management.

Vildagliptin — The DPP-4 Inhibitor

Vildagliptin belongs to the class of DPP-4, and it is also called gliptins. It blocks the enzyme DPP-4, which is responsible for breaking down incretin hormones like GLP-1. When these hormones are preserved, the pancreas receives better signals to release insulin after meals.

Metformin Hydrochloride — The Insulin Sensitizer

Metformin is the most prescribed anti-diabetic drug, and it is considered the first-line treatment for Type 2 diabetes. It reduces the glucose production in the liver and improves the sensitivity to insulin in the body.

Why combine them? Vidagliptin targets the postprandial glucose, and Metformin targets the fasting glucose and insulin resistance. Together, they provide comprehensive 24-hour blood sugar control with complementary mechanisms.

List of Top Vildagliptin and Metformin Hydrochloride Tablets in India

The Indian pharmaceutical market has several brands in this category. Let’s look at the major players:

VEGLISAP-M-FORTE

Marketer – Saphnix Lifecare

VEGLISAP-M FORTE (50/1000 mg) is a flagship anti-diabetic combination tablet offered by Saphnix Lifecare. It is a WHO-GMP-certified pharmaceutical company. This product is designed for patients who need maximum Metformin strength and Vildagliptin for better glycemic control. Our company focuses on high-quality manufacturing and affordable prices. Saphnix holds ISO-GMP certifications and provides these products through our PCD pharma franchise network across India.

Galvus Met

Marketer – Cipla Ltd.

Galvus Met is one of the most recognized and widely prescribed brands in this combination in India. Cipla is one of the largest pharma companies, and this tablet is available in both 50/500 mg and 50/100 mg strengths. It has a strong presence in the hospitals, clinics, and retail pharmacies throughout India.

Zomelis Met

Marketer – Eris Lifesciences

Eris Lifesciences is known for its strong chronic therapy portfolio. This combination medicine contains 50/500 mg and 50/1000 mg strengths. This company has built a strong reputation in the diabetic and cardiovascular segment. It is a regularly prescribed medicine in the tier 2 and tier 3 cities.

Vildamac M

Marketer – Macleods Pharmaceuticals

Macledos is a global generic company with a strong diabetic range. This tablet is available in 50/500 mg and 50/1000 mg doses, and it is also known for its competitive prices in the local market. The company guarantees consistent quality of the medicine so that it can provide reliable results to a wide number of patients.

Torglip – M

Marketer – Torrent Pharmaceuticals

Torrent is one of the top five pharma companies in India. Torglip – M is available in 50/500 mg and 50/850 mg dosages. It is backed by the strong field force of the Torrent. This medicine has made an impact in improving diabetic issues in patients. This tablet has a strong brand credibility in the diabetes segment.

Verifica – M

Marketer – Lupin Ltd

Lupin is a globally recognized Indian pharma company. This tablet is widely prescribed in the market due to its comprehensive dosage for 50/500 mg and 50/850 mg formulations. It is commonly seen in pharmacies and healthcare clinics. The company has made a strong impact in the healthcare sector by providing reliable medicines.

Gliptagreat M 500

Marketer – Mankind Pharma

Mankind Pharma is a trusted and fast-growing pharma company. It has made its name with a deep reach in the rural and semi-urban markets. Gliptagreat M 500 (50/500 mg) is a part of the anti-diabetic portfolio of the company. This medicine is popular in the price-sensitive markets due to its affordability.

PCD Pharma Franchise for Vildagliptin and Metformin Hydrochloride Tablet

Saphnix Lifecare offers a lucrative PCD pharma franchise opportunity for the VEGLISAP-M-FORTE. The combination of our WHO-GMP certified manufacturing facility, our exclusive distribution rights and marketing assistance, and our ability to deliver products on schedule establishes us as a dependable business partner. 

Saphnix Lifecare is a dedicated Cardiac-diabetic PCD pharma franchise company operating under the umbrella of Saphnix Life Sciences. Our company distinguishes itself from competitors through our WHO-GMP certified manufacturing facility by producing products that meet strict quality requirements. The ISO certification of our product portfolio ensures that every item we produce complies with established quality standards.

Our franchise partners receive exclusive territory rights through our monopoly rights. Our company maintains a dependable supply chain system, which enables us to deliver products according to your business requirements. Additionally, our company designates itself as a specialized provider of medical products that treat cardiac conditions and diabetes throughout India.

Pharma professionals, distributors, and entrepreneurs who wish to enter the growing diabetes and cardiac pharma segment can establish a partnership with Saphnix Lifecare for strategic and profitable business operations.

Conclusion

The Vildagliptin and Metformin Hydrochloride combination represents a clinically approved approach to managing Type 2 diabetes in India. There are multiple brands available from the major pharma companies. Veglisap-M Forte is suitable to cater to the different clinical needs and budgets.

For the pharma businesses looking to build or expand in the diabetic segment, this therapeutic category offers a significant market potential. To know more about these tablets or the PCD pharma franchise opportunity, you can visit us.